229 related articles for article (PubMed ID: 23039284)
1. Selective pharmacological inhibition of phosphoinositide 3-kinase p110delta opposes the progression of autoimmune diabetes in non-obese diabetic (NOD) mice.
Durand CA; Richer MJ; Brenker K; Graves M; Shanina I; Choi K; Horwitz MS; Puri KD; Gold MR
Autoimmunity; 2013 Feb; 46(1):62-73. PubMed ID: 23039284
[TBL] [Abstract][Full Text] [Related]
2. Preventive and therapeutic potential of p38 alpha-selective mitogen-activated protein kinase inhibitor in nonobese diabetic mice with type 1 diabetes.
Medicherla S; Protter AA; Ma JY; Mangadu R; Almirez R; Koppelman B; Kerr I; Navas TA; Movius F; Reddy M; Liu YW; Luedtke G; Perumattam J; Mavunkel B; Dugar S; Schreiner GF
J Pharmacol Exp Ther; 2006 Jul; 318(1):99-107. PubMed ID: 16603672
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of Phosphoinositide 3-Kinase p110delta Does Not Affect T Cell Driven Development of Type 1 Diabetes Despite Significant Effects on Cytokine Production.
Barbera Betancourt A; Emery JL; Recino A; Wong FS; Cooke A; Okkenhaug K; Wallberg M
PLoS One; 2016; 11(1):e0146516. PubMed ID: 26783747
[TBL] [Abstract][Full Text] [Related]
4. Insulin-producing intestinal K cells protect nonobese diabetic mice from autoimmune diabetes.
Mojibian M; Lam AW; Fujita Y; Asadi A; Grassl GA; Dickie P; Tan R; Cheung AT; Kieffer TJ
Gastroenterology; 2014 Jul; 147(1):162-171.e6. PubMed ID: 24662331
[TBL] [Abstract][Full Text] [Related]
5. I-Ag7-mediated antigen presentation by B lymphocytes is critical in overcoming a checkpoint in T cell tolerance to islet beta cells of nonobese diabetic mice.
Noorchashm H; Lieu YK; Noorchashm N; Rostami SY; Greeley SA; Schlachterman A; Song HK; Noto LE; Jevnikar AM; Barker CF; Naji A
J Immunol; 1999 Jul; 163(2):743-50. PubMed ID: 10395666
[TBL] [Abstract][Full Text] [Related]
6. Upregulating CD4+CD25+FOXP3+ regulatory T cells in pancreatic lymph nodes in diabetic NOD mice by adjuvant immunotherapy.
Tian B; Hao J; Zhang Y; Tian L; Yi H; O'Brien TD; Sutherland DE; Hering BJ; Guo Z
Transplantation; 2009 Jan; 87(2):198-206. PubMed ID: 19155973
[TBL] [Abstract][Full Text] [Related]
7. The DPP4 inhibitor linagliptin delays the onset of diabetes and preserves β-cell mass in non-obese diabetic mice.
Jelsing J; Vrang N; van Witteloostuijn SB; Mark M; Klein T
J Endocrinol; 2012 Sep; 214(3):381-7. PubMed ID: 22761275
[TBL] [Abstract][Full Text] [Related]
8. AEB-071 has minimal impact on onset of autoimmune diabetes in NOD mice.
Merani S; Edgar RL; Toso C; Emamaullee J; Thiesen A; Shapiro AM
Autoimmunity; 2009 Mar; 42(3):242-8. PubMed ID: 19301207
[TBL] [Abstract][Full Text] [Related]
9. Neutrophil elastase triggers the development of autoimmune diabetes by exacerbating innate immune responses in pancreatic islets of non-obese diabetic mice.
Shu L; Zhong L; Xiao Y; Wu X; Liu Y; Jiang X; Tang T; Hoo R; Zhou Z; Xu A
Clin Sci (Lond); 2020 Jul; 134(13):1679-1696. PubMed ID: 32633320
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of phosphoinositide 3-kinase delta attenuates allergic airway inflammation and hyperresponsiveness in murine asthma model.
Lee KS; Lee HK; Hayflick JS; Lee YC; Puri KD
FASEB J; 2006 Mar; 20(3):455-65. PubMed ID: 16507763
[TBL] [Abstract][Full Text] [Related]
11. B lymphocytes are crucial antigen-presenting cells in the pathogenic autoimmune response to GAD65 antigen in nonobese diabetic mice.
Falcone M; Lee J; Patstone G; Yeung B; Sarvetnick N
J Immunol; 1998 Aug; 161(3):1163-8. PubMed ID: 9686575
[TBL] [Abstract][Full Text] [Related]
12. Development of insulitis and diabetes in B cell-deficient NOD mice.
Yang M; Charlton B; Gautam AM
J Autoimmun; 1997 Jun; 10(3):257-60. PubMed ID: 9218752
[TBL] [Abstract][Full Text] [Related]
13. Persistence of residual beta cells and islet autoimmunity during increasing duration of diabetes in NOD mice and experimental approaches toward reversing new-onset disease with bioactive peptides.
Reddy S; Cheung CC; Chai RC; Rodrigues JA
Ann N Y Acad Sci; 2008 Dec; 1150():171-6. PubMed ID: 19120289
[TBL] [Abstract][Full Text] [Related]
14. Selective inhibitors of phosphoinositide 3-kinase delta: modulators of B-cell function with potential for treating autoimmune inflammatory diseases and B-cell malignancies.
Puri KD; Gold MR
Front Immunol; 2012; 3():256. PubMed ID: 22936933
[TBL] [Abstract][Full Text] [Related]
15. PI3Kδ drives the pathogenesis of experimental autoimmune encephalomyelitis by inhibiting effector T cell apoptosis and promoting Th17 differentiation.
Haylock-Jacobs S; Comerford I; Bunting M; Kara E; Townley S; Klingler-Hoffmann M; Vanhaesebroeck B; Puri KD; McColl SR
J Autoimmun; 2011 May; 36(3-4):278-87. PubMed ID: 21396797
[TBL] [Abstract][Full Text] [Related]
16. Marginal-zone B-cells of nonobese diabetic mice expand with diabetes onset, invade the pancreatic lymph nodes, and present autoantigen to diabetogenic T-cells.
Mariño E; Batten M; Groom J; Walters S; Liuwantara D; Mackay F; Grey ST
Diabetes; 2008 Feb; 57(2):395-404. PubMed ID: 18025414
[TBL] [Abstract][Full Text] [Related]
17. Transgenic expression of single-chain anti-CTLA-4 Fv on beta cells protects nonobese diabetic mice from autoimmune diabetes.
Shieh SJ; Chou FC; Yu PN; Lin WC; Chang DM; Roffler SR; Sytwu HK
J Immunol; 2009 Aug; 183(4):2277-85. PubMed ID: 19635924
[TBL] [Abstract][Full Text] [Related]
18. Interleukin 13 increases contractility of murine tracheal smooth muscle by a phosphoinositide 3-kinase p110delta-dependent mechanism.
Farghaly HS; Blagbrough IS; Medina-Tato DA; Watson ML
Mol Pharmacol; 2008 May; 73(5):1530-7. PubMed ID: 18276774
[TBL] [Abstract][Full Text] [Related]
19. Phenotype and functional characteristics of islet-infiltrating B-cells suggest the existence of immune regulatory mechanisms in islet milieu.
Puertas MC; Carrillo J; Pastor X; Ampudia RM; Alba A; Planas R; Pujol-Borrell R; Vives-Pi M; Verdaguer J
Diabetes; 2007 Apr; 56(4):940-9. PubMed ID: 17395741
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of PI3Kδ reduces kidney infiltration by macrophages and ameliorates systemic lupus in the mouse.
Suárez-Fueyo A; Rojas JM; Cariaga AE; García E; Steiner BH; Barber DF; Puri KD; Carrera AC
J Immunol; 2014 Jul; 193(2):544-54. PubMed ID: 24935930
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
